What is the current valuation of the South Korea radiology services market as of 2024?

The market valuation was $1000.42 Million in 2024. Read More

What is the projected market valuation for the South Korea radiology services market in 2035?

The projected valuation for 2035 is $1625.0 Million. Read More

What is the expected CAGR for the South Korea radiology services market during the forecast period 2025 - 2035?

The expected CAGR is 4.51% during the forecast period 2025 - 2035. Read More

Which imaging techniques are included in the South Korea radiology services market, and what were their valuations in 2024?

In 2024, X-Ray was valued at $200.0 - $320.0 Million, Ultrasound at $150.0 - $240.0 Million, CT at $250.0 - $400.0 Million, MRI at $300.0 - $480.0 Million, and Nuclear Medicine at $100.42 - $185.0 Million. Read More

What are the key service types in the South Korea radiology services market, and what were their valuations in 2024?

In 2024, Diagnostic Imaging was valued at $400.0 - $650.0 Million, Interventional Radiology at $300.0 - $475.0 Million, and Radiation Oncology at $300.42 - $500.0 Million. Read More

Who are the key players in the South Korea radiology services market?

Key players include Radiology Partners, Fujifilm Holdings Corporation, Siemens Healthineers, GE Healthcare, Philips Healthcare, Canon Medical Systems Corporation, Hologic, Inc., and Agfa-Gevaert Group. Read More

What were the valuations for different end users in the South Korea radiology services market in 2024?

In 2024, Hospitals were valued at $400.17 - $650.0 Million, Diagnostic Imaging Centers at $300.13 - $500.0 Million, Outpatient Clinics at $200.08 - $350.0 Million, and Research Institutions at $100.04 - $125.0 Million. Read More

What applications are covered in the South Korea radiology services market, and what were their valuations in 2024?

In 2024, Oncology was valued at $200.0 - $320.0 Million, Cardiology at $250.0 - $400.0 Million, Neurology at $300.0 - $450.0 Million, and Orthopedics at $250.42 - $455.0 Million. Read More

How does the South Korea radiology services market compare to other regions?

While specific regional comparisons are not provided, the growth trajectory and key players suggest a competitive landscape in South Korea. Read More

What trends are influencing the growth of the South Korea radiology services market?

Trends such as technological advancements in imaging techniques and increasing demand for diagnostic services appear to drive growth in the market. Read More

South Korea Radiology Services Market

ID: MRFR/HC/48985-HCR

200 Pages

Vikita Thakur

Last Updated: April 06, 2026

South Korea Radiology Services Market Research Report: Size, Share, Trend Analysis By Imaging Technique (X-ray, Ultrasound, Computed Tomography, Magnetic Resonance Imaging, Nuclear Medicine), By Service Type (Diagnostic Imaging, Interventional Radiology, Radiation Oncology), By End Users (Hospitals, Diagnostic Imaging Centers, Outpatient Clinics, Research Institutions) and By Applications (Oncology, Cardiology, Neurology, Orthopedics) - Growth Outlook & Industry Forecast 2025 To 2035

South Korea Radiology Services Market Infographic

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Pharmaceutical, BY Imaging Technique (USD Million)
  1. 4.1.1 X-Ray
  2. 4.1.2 Ultrasound
  3. 4.1.3 Computed Tomography
  4. 4.1.4 Magnetic Resonance Imaging
  5. 4.1.5 Nuclear Medicine
2. 4.2 Pharmaceutical, BY Service Type (USD Million)
  1. 4.2.1 Diagnostic Imaging
  2. 4.2.2 Interventional Radiology
  3. 4.2.3 Radiation Oncology
3. 4.3 Pharmaceutical, BY End User (USD Million)
  1. 4.3.1 Hospitals
  2. 4.3.2 Diagnostic Imaging Centers
  3. 4.3.3 Outpatient Clinics
  4. 4.3.4 Research Institutions
4. 4.4 Pharmaceutical, BY Application (USD Million)
  1. 4.4.1 Oncology
  2. 4.4.2 Cardiology
  3. 4.4.3 Neurology
  4. 4.4.4 Orthopedics
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Pharmaceutical
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Pharmaceutical
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Radiology Partners (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Fujifilm Holdings Corporation (JP)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Siemens Healthineers (DE)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 GE Healthcare (US)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Philips Healthcare (NL)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Canon Medical Systems Corporation (JP)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Hologic, Inc. (US)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Agfa-Gevaert Group (BE)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 SOUTH KOREA MARKET ANALYSIS BY IMAGING TECHNIQUE
3. 6.3 SOUTH KOREA MARKET ANALYSIS BY SERVICE TYPE
4. 6.4 SOUTH KOREA MARKET ANALYSIS BY END USER
5. 6.5 SOUTH KOREA MARKET ANALYSIS BY APPLICATION
6. 6.6 KEY BUYING CRITERIA OF PHARMACEUTICAL
7. 6.7 RESEARCH PROCESS OF MRFR
8. 6.8 DRO ANALYSIS OF PHARMACEUTICAL
9. 6.9 DRIVERS IMPACT ANALYSIS: PHARMACEUTICAL
10. 6.10 RESTRAINTS IMPACT ANALYSIS: PHARMACEUTICAL
11. 6.11 SUPPLY / VALUE CHAIN: PHARMACEUTICAL
12. 6.12 PHARMACEUTICAL, BY IMAGING TECHNIQUE, 2024 (% SHARE)
13. 6.13 PHARMACEUTICAL, BY IMAGING TECHNIQUE, 2024 TO 2035 (USD Million)
14. 6.14 PHARMACEUTICAL, BY SERVICE TYPE, 2024 (% SHARE)
15. 6.15 PHARMACEUTICAL, BY SERVICE TYPE, 2024 TO 2035 (USD Million)
16. 6.16 PHARMACEUTICAL, BY END USER, 2024 (% SHARE)
17. 6.17 PHARMACEUTICAL, BY END USER, 2024 TO 2035 (USD Million)
18. 6.18 PHARMACEUTICAL, BY APPLICATION, 2024 (% SHARE)
19. 6.19 PHARMACEUTICAL, BY APPLICATION, 2024 TO 2035 (USD Million)
20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 South Korea MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY IMAGING TECHNIQUE, 2025-2035 (USD Million)
  2. 7.2.2 BY SERVICE TYPE, 2025-2035 (USD Million)
  3. 7.2.3 BY END USER, 2025-2035 (USD Million)
  4. 7.2.4 BY APPLICATION, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

South Korea Pharmaceutical Market Segmentation

Pharmaceutical By Imaging Technique (USD Million, 2025-2035)

X-Ray
Ultrasound
Computed Tomography
Magnetic Resonance Imaging
Nuclear Medicine

Pharmaceutical By Service Type (USD Million, 2025-2035)

Diagnostic Imaging
Interventional Radiology
Radiation Oncology

Pharmaceutical By End User (USD Million, 2025-2035)

Hospitals
Diagnostic Imaging Centers
Outpatient Clinics
Research Institutions

Pharmaceutical By Application (USD Million, 2025-2035)

Oncology
Cardiology
Neurology
Orthopedics

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”